China Biotech - Coming of age?

Pininvest Analysis on Health Care •

To live up to the challenge and address the chronic diseases afflicting the population, biotech in China is committed for the long haul - R&D outcomes remain fickle and international license agreements get caught up in geopolitics

1 more article in China Biotech - Rising Stars ?